1. Home
  2. TPST vs VNCE Comparison

TPST vs VNCE Comparison

Compare TPST & VNCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPST
  • VNCE
  • Stock Information
  • Founded
  • TPST 2011
  • VNCE 2002
  • Country
  • TPST United States
  • VNCE United States
  • Employees
  • TPST N/A
  • VNCE N/A
  • Industry
  • TPST Biotechnology: Pharmaceutical Preparations
  • VNCE Clothing/Shoe/Accessory Stores
  • Sector
  • TPST Health Care
  • VNCE Consumer Discretionary
  • Exchange
  • TPST Nasdaq
  • VNCE Nasdaq
  • Market Cap
  • TPST 40.4M
  • VNCE 38.3M
  • IPO Year
  • TPST N/A
  • VNCE 2013
  • Fundamental
  • Price
  • TPST $0.86
  • VNCE $2.59
  • Analyst Decision
  • TPST Strong Buy
  • VNCE Strong Buy
  • Analyst Count
  • TPST 3
  • VNCE 2
  • Target Price
  • TPST $21.67
  • VNCE $4.50
  • AVG Volume (30 Days)
  • TPST 877.6K
  • VNCE 306.0K
  • Earning Date
  • TPST 03-18-2025
  • VNCE 12-10-2024
  • Dividend Yield
  • TPST N/A
  • VNCE N/A
  • EPS Growth
  • TPST N/A
  • VNCE N/A
  • EPS
  • TPST N/A
  • VNCE 0.37
  • Revenue
  • TPST N/A
  • VNCE $288,813,000.00
  • Revenue This Year
  • TPST N/A
  • VNCE N/A
  • Revenue Next Year
  • TPST N/A
  • VNCE $5.81
  • P/E Ratio
  • TPST N/A
  • VNCE $7.02
  • Revenue Growth
  • TPST N/A
  • VNCE N/A
  • 52 Week Low
  • TPST $0.70
  • VNCE $1.27
  • 52 Week High
  • TPST $6.00
  • VNCE $6.89
  • Technical
  • Relative Strength Index (RSI)
  • TPST 40.89
  • VNCE 38.46
  • Support Level
  • TPST $0.85
  • VNCE $2.70
  • Resistance Level
  • TPST $0.95
  • VNCE $3.04
  • Average True Range (ATR)
  • TPST 0.05
  • VNCE 0.28
  • MACD
  • TPST -0.00
  • VNCE -0.08
  • Stochastic Oscillator
  • TPST 9.45
  • VNCE 8.18

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale, Vince Direct-to-consumer, and Rebecca Taylor and Parker segment. It operates its e-commerce business through its website. Majority of its revenue generated from Vince Wholesale segment.

Share on Social Networks: